Our Partners


AstraZeneca

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company, engaged in the discovery, development, manufacture and marketing of prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. AstraZeneca employs around 57,200 people worldwide, including 11,300 in its R&D organisation, and invests over $4 billion in R&D each year.

Merck

Merck is the world’s oldest pharmaceutical and chemical company. Its historical roots lie in Darmstadt, where Friedrich Jacob Merck acquired the Engel-Apotheke (“Angel Pharmacy”) in 1668. It is a leading biopharmaceutical company engaged in the research and development of medicines in oncology, neurodegenerative diseases, fertility, endocrinology and cardiometabolic care. It employs approximately 17,000 people worldwide and its products are commercialized in 150 countries.

Lundbeck

Lundbeck is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and Parkinson’s diseases. Lundbeck employs 6,000 people worldwide, of whom 1,200 work in its R&D units. Each year, Lundbeck ploughs back around 20% of its revenue into research and development of new pharmaceuticals.

Recordati

Recordati, established in 1926, is a European group with a total staff of over 3,200, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. It has headquarters in Milan, Italy, and operations in the main European countries, in Central and Eastern Europe. Recordati is committed to the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases.

Meda

Meda is an international specialty pharma company based in Solna, Sweden. Meda has a total staff of approximately 2,600 people, with own operations in 50 countries. Meda’s products are available in more than 120 countries, and it is about the 50th largest pharmaceutical company in the world by sales.

Galderma

One of the world’s leading dermatology companies, founded in 1981 as a joint venture between Nestlé and L’Oréal. Galderma employs nearly 4,000 employees worldwide and its products are distributed in over 70 countries. Approximately 20% of revenues are invested annually to discover and develop new drugs. Galderma’s research efforts have allowed the company to issue 1700 scientific publications, develop more than 550 inventions and file 5500 patent applications and patents.

WinMedica

WinMedica is a Greek pharmaceutical company marketing a wide range of products in Greece. Its strategy focuses on marketing original pharmaceuticals through alliances with research-based international companies, on value added generics and biosimilars and on high quality non-prescription products. In 2017 Winmedica and Papaloisou signed an agreement for the marketing and distribution of non-prescription (OTC) products in Cyprus.

Neurim

Neurim Pharmaceuticals is a drug discovery and development company, founded in 1991 and focused on age-related disorders such as insomnia and Alzheimer’s disease, primarily in the central nervous system (CNS). Neurim’s first approved drug, Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific and the Middle East.